Therapeutic potential of fractalkine: a novel approach to metastatic colon cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17339240.
- Also identified by PMC identifier 1856811.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fractalkine is involved in the pathogenesis of different types of cancer and in various clinical disease states
Medical subject headings
- Chemokines, CX3C
- Colonic Neoplasms
- Immunotherapy
- Membrane Proteins